… the role of OSKM in inducing pluripotency and stem cell-like … Yamanaka factors’ role in
stemness and chemoresistance of … of the major reasons for stemness and drug resistance and is …

This study defines a previously uncharacterized role of nicotine-regulated ILF2 in facilitating
nuclear mRNA export to promote cancer stemness, suggesting a potential therapeutic …

… Research indicates that CDK1 can directly influence the function of various pluripotency
factors such as Nanog, Sox2, and Oct4. The CDK1/cyclin A complex can phosphorylate Nanog, …

… factor FOXO3 activates expression of pluripotency factors in response to chemotherapy in
… in A2BR-induced pluripotency factor expression in response to chemotherapy, we searched …

… Various other OCT4-dependent mechanisms are thought to be involved in chemoresistance.
… an important role in tumor-associated chemoresistance and suggests that inhibition of the …

… The mRNA expression and protein levels of the major pluripotency factors OCT4, NANOG,
SOX2 and LIN28 were all reduced in response to CPEB1 overexpression, significantly for …

… We demonstrate that carboplatin can induce the self-renewal (spherogenesis) and
pluripotency (Sox2 and oct3/4 expression) of hepatocellular carcinoma (HCC) cells grown under …

… pluripotency factors common in ovarian CSCs including OCT4, MYC, and ARID3B will provide
clarity for how cancer stemness … pathways involved in stemness and chemoresistance, we …

… Pluripotency factors and signaling pathways, which regulate and modulate cancer stemness
are … of stemness factor genes and increased drug resistance [134]. Finally, tumor necrosis …

… stem cells, significantly affects drug resistance acquisition. Transcription factors in the Snail
family have been implicated in ovarian cancer chemoresistance and metastasis. In this article…